Diseases, Conditions, Syndromes

Improving treatment for systemic amyloidosis

A potential new approach to treat systemic amyloidosis, invented at UCL and being developed by GlaxoSmithKline (GSK), marks the start of a successful and innovative academic-industry collaboration.

Diseases, Conditions, Syndromes

Amyloid formation may link Alzheimer disease and type 2 diabetes

The pathological process amyloidosis, in which misfolded proteins (amyloids) form insoluble fibril deposits, occurs in many diseases, including Alzheimer disease (AD) and type 2 diabetes mellitus (T2D). However, little is ...

Diabetes

Gender-specific approach to diabetes

The international guidelines on the drug-based therapy of diabetes mellitus specify which factors need to be taken into account during treatment. Factors such as age, the duration of the condition, life expectancy, the social ...

page 11 from 18